HB1565sam001 103RD GENERAL ASSEMBLY

Sen. Meg Loughran Cappel

Filed: 4/14/2023

10300HB1565sam001 LRB103 25816 BMS 60088 a

AMENDMENT TO HOUSE BILL 1565

AMENDMENT NO. ______. Amend House Bill 1565 by replacing line 23 on page 8 through line 11 on page 9 with the following: "vaginal estrogen in its formulary.

(b) If a particular vaginal estrogen product or its therapeutic equivalent version approved by the United States Food and Drug Administration is determined to be medically necessary, the issuer must cover that service or item pursuant to the cost-sharing requirement contained in subsection (c).

(c) A policy subject to this Section shall not impose a deductible, copayment, or any other cost sharing requirement that exceeds any deductible, coinsurance, copayment, or any other cost-sharing requirement imposed on any prescription drug authorized for the treatment of erectile dysfunction covered by the policy; except that this".